Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05244447 · ClinicalTrials.gov registry record · NA
IVROP ReadyforLIFE Program Evaluation
A NA study of Youth, sponsored by Midwest Evaluation & Research.
- Completed
- Registry status
- NA
- Development phase
- 1,054
- Enrollment target
- 1
- Study location
NCT05244447: Completed NA study of Youth, sponsored by Midwest Evaluation & Research.
NCT05244447 is a NA study of Youth that has completed, run by Midwest Evaluation & Research. The registered enrollment target is 1,054 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05244447, a NA study of Youth, has completed, sponsored by Midwest Evaluation & Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,054 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the Imperial Valley Regional Occupational Program (IVROP) ReadyforLIFE program evaluation is to determine whether primary (i.e., behaviors) and secondary (i.e., attitudes) outcomes improve for youth participants after completing the ReadyforLIFE program. Understanding the ways in which the IVROP ReadyforLIFE program supports healthy partner relationships and economic stability is important for those providing services to at-risk youth populations.
Primary Outcome
Will participants report significantly healthier relationship behaviors one year after enrolling into the IVROP ReadyforLIFE program? Items measured include: 5 items: levels of reported skill with key relationship behaviors (categories, 4-point scale); measured on the Healthy Relationship Behavior Scale #1 as: 1 = I am extremely good at this 2 = I am good at this 3 = I am bad at this 4 = I am extremely bad at this Lower scores indicate a higher perceived skill in healthy relationship behavior
Conditions Studied
Interventions
- OTHER Primary Services
Study Locations (1)
California
- Imperial Valley Regional Occupational Program Community Foundation (IVROPCF) - El Centro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,054 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2025-02-01 |
| Phase | NA |
What the finished NCT05244447 record still lists
NCT05244447 is an interventional study that assigns participants to a tested intervention. Its 1,054 participants enrollment target places it among the larger protocols in the corpus, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (25% lower).
The record links to 1 condition, with Youth appearing as the primary indexed condition, and to 1 intervention - of which Primary Services is the first listed.
NCT05244447 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05244447 about?
NCT05244447 is a clinical study titled "IVROP ReadyforLIFE Program Evaluation". The purpose of the Imperial Valley Regional Occupational Program (IVROP) ReadyforLIFE program evaluation is to determine whether primary (i.e., behaviors) and secondary (i.e., attitudes) outcomes improve for youth participants after completing the ReadyforLIFE program. Understanding the ways in whic...
What is the current status of trial NCT05244447?
This trial is currently completed. It is a NA study. The enrollment target is 1,054 participants. The study started on 2021-04-01. Estimated completion is 2025-02-01.
What conditions does trial NCT05244447 study?
This clinical trial studies the following conditions: Youth.
What interventions are being tested in trial NCT05244447?
The interventions under investigation include: Primary Services (OTHER).
Who is sponsoring clinical trial NCT05244447?
This trial is sponsored by Midwest Evaluation & Research, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05244447 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Youth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05244447's enrollment target sits among peer trials
1,054 99th of 2000 higher than 1,902 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03242642 · 1,056 participants · NA
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
- NCT04372108 · 1,056 participants
A Study to Assess the Long-Term Safety of Ustekinumab Versus Other Biologics in Patients With Crohn's Disease and Ulcerative Colitis
- NCT07018869 · 1,057 participants · Phase 3
Evaluating Whether an Educational Website Called Current Together After Cancer (CTAC) Improves Follow-up Care for Colorectal Cancer Survivors
- NCT03588286 · 1,058 participants · NA
Programmed Ventricular Stimulation to Risk Stratify for Early Cardioverter-Defibrillator (ICD) Implantation to Prevent Tachyarrhythmias Following Acute Myocardial Infarction (PROTECT-ICD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI